FDA to review Merck diabetes drug combo
The Food and Drug Administration will review Merck’s plan to market their drug Januvia and the older, generic drug metformin as a combination that together may decrease blood sugar levels in diabetics. A ruling is expected by October.
Merck is developing a combination of the two drugs in a single pill that it plans to sell as Janumet.
In a study conducted by Merck, two thirds of patients who took the combination saw blood sugar levels fall to acceptable levels, compared with 38 percent who took metformin alone.
(via Asbury Park NJ Press
0 opinions for FDA to review Merck diabetes drug combo
No one has left a comment yet. You know what this means, right? You could be first!
Have an opinion? Leave a comment: